Please login to the form below

Not currently logged in
Email:
Password:

Bayer's Kirstyn Nicholas joins Spirit Healthcare

Takes up role as regional business director

edit-Spirit-Healthcare-Kirstyn-NicholasLeicestershire, UK, based Spirit Healthcare has named Kirstyn Nicholas as regional business director.

Nicholas joins from Bayer, where she was principal territory manager for almost ten years.

The role included working with CCG leads, consultants and clinical scientists and prior to that she worked as healthcare development manager at Bayer HealthCare.

Commenting on her appointment, Nicholas said: “I am thrilled to be working for such a refreshingly innovative company that provides a range of high quality products and solution as well as the internal knowledge, passion and commitment to improve patient lives.”

Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.

Chris Barker, chief executive of Spirit Healthcare, added: “Kirstyn has only been with the company a few weeks and has already made a significant contribution. It is great to have such talent on the team as we continue to expand.”

The expansion follows the successful launch of EMPOWER Structured Diabetes Education and the introduction of TEE2 to its diabetes portfolio.

Spirit Healthcare is a provider of healthcare solution to the NHS and private hospitals, recently winning a PMEA award for Excellence in Healthcare Collaboration and Partnerships Leicester City TotalCare Project.

11th February 2015

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...